Jour,
well reasoned, our ceo said as much when he mentioned
capturing the prize nasdaq in 2-3 years!
but:
can not predict"
take over bid, merger, markets reception of eli201-202-216
human well purepac have river cards to flop over also
what reception?
whenever a biotech has a drug approved it dramatically changes
the dynamics value, of company
slow down snup
okay get it they run the no's, connect the dots on future value,
r+d gets a rightfull valuation for pps at supper table
no, fda saying hell yeah to our tech.platform one bead two bead
approach is a big deal.
snup raise em!